Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: CD34+ Transplants for Leukemia and Lymphoma [Phase 2]
A Phase 2 clinical trial update on CD34+ transplants for acute myeloid leukemia and acute lymphoblastic leukemia, currently not recruiting.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia [Phase 1]
Early-phase clinical trial investigating a combination of azacitidine, venetoclax, and eganelisib to target PI3K gamma in patients with acut…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia [NA]
This clinical trial update from Massachusetts General Hospital describes a collaborative palliative and oncology care model for patients wit…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality [Phase 4]
A Phase 4 clinical trial evaluating oral azacitidine in transplant-eligible adults with acute myeloid leukemia experiencing health inequalit…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy [Phase 1]
This clinical trial update describes a Phase 1 study of edetate calcium disodium or succimer in patients with acute myeloid leukemia or myel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Clinical Study to Explore the Safety and Efficacy of CT1390B in Relapsed/ Refractory Acute Myeloid Leukemia [Phase 1]
A Phase 1 clinical study evaluating CT1390B for relapsed/refractory acute myeloid leukemia is currently not recruiting.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration
A clinical trial update from Washington University School of Medicine on in vivo chemotherapy–mediated drug sensitization for acute myeloid …
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients [Phase 3]
A Phase 3 clinical trial in China is comparing VA versus D/IA induction regimens in elderly fit patients with acute myeloid leukemia; recrui…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia [Phase 1]
Phase 1 trial evaluating the safety of a multi-agent regimen (CDX-1401, Poly ICLC, Decitabine, and Nivolumab) in patients with myelodysplast…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies [Phase 2]
Phase 2 clinical trial update describing a donor stem cell transplant conditioning regimen with treosulfan, fludarabine, and total-body irra…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML [Phase 1]
Phase 1 trial update evaluating CPX-351 in combination with gemtuzumab ozogamicin for newly diagnosed Acute Myeloid Leukemia; the study is c…
-
CLINICAL_TRIALS other · 2026-02-27Clinical Trial Update: Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD [Phase 2]
Phase 2 trial in acute myeloid leukemia with measurable residual disease reports discontinuation of a hypomethylating agent and venetoclax; …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML [Phase 2]
A Phase 2 clinical trial update describes using Selinexor in combination with induction chemotherapy for children with NUP98 fusion-positive…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood [Phase 2]
Phase 2 clinical trial evaluating co-transplant of an unmodified haplo-identical graft with cord blood; the study targets acute graft-versus…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia [Phase 3]
A Phase 3 clinical trial sponsored by the Children's Oncology Group is evaluating whether xylitol dental wipes can reduce bloodstream infect…
-
EMA approval · 2026-02-25EMA Authorised: Tibsovo (Ivosidenib) — Les Laboratoires Servier
The European Medicines Agency authorised Tibsovo (ivosidenib) for acute myeloid leukemia and cholangiocarcinoma in the EU, with Les Laborato…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Clinical Study on the Safety, Efficacy and Pharmacokinetics of Universal CLL1 Chimeric Antigen Receptor T-Cell in Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]
A Phase 1 study evaluating the safety, efficacy and pharmacokinetics of universal CLL1-targeted CAR-T cells in relapsed/refractory acute mye…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: A Study of BN104 in the Treatment of Acute Leukemia [Phase 1, Phase 2]
BN104 is being studied in Phase 1/2 trials for acute leukemia; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
A Phase 1/2 clinical trial is investigating Cytokine-Induced Memory-Like Natural Killer (CIML-NK) cells as a treatment for relapsed or refra…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts [Phase 1]
Phase 1 study evaluating talazoparib for cohesin-mutated acute myeloid leukemia and myelodysplastic syndrome with excess blasts; the trial i…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies [Phase 1, Phase 2]
A first-in-human study evaluating HLA partially to fully matched allogeneic, cryopreserved deceased donor bone marrow transplantation for va…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations [Phase 3]
Phase 3 clinical trial comparing standard chemotherapy to therapy with CPX-351 and/or gilteritinib for newly diagnosed acute myeloid leukemi…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
A clinical trial update describing a study to learn more about the health of persons with Down syndrome after treatment for acute leukemia.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia [NA]
This clinical trial (NCT06945042) investigates the impact of systematic financial navigation on patients with acute myeloid leukemia and is …
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Phase I Study of Q702 With Azacitidine and Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
A Phase I clinical trial evaluating Q702 in combination with azacitidine and venetoclax for relapsed or refractory acute myeloid leukemia is…